Arphra AIPlain-English read on Protalix BioTherapeutics, Inc.’s valuation
Valuation read
Valuation snapshot
Each multiple is placed against its own 5-year range (the dot is the historical percentile of today’s value) and the peer-set sector median. key_metrics_ttm
Multiples · current vs 5-year range vs sector
marker = today’s percentile · sector = peer median
Metric
Current
5-year range
%ile
Sector
Read
P / E (TTM)
—
—
—
—
—
PEG
—
—
—
—
—
EV / EBITDA
—
—
—
—
—
EV / Sales
1.7×
1.6
1.8
67
—
—
P / S
—
—
—
—
—
P / B
—
—
—
—
—
EV / FCF
9.1×
8.6
9.2
67
—
—
FCF yield
8.82%
8.7
9.2
50
—
—
Pro
Multiples
Valuation multiples and peer comparisons are included with Pro.